HEADS of some 80 multinationals including Siemens, Apple, Samsung and Pfizer have flocked to China to seek new cooperation opportunities with the world’s second-largest economy.
The transnational corporate chiefs were present at the China Development Forum 2025 in Beijing, scheduled from 23 to 24 March. The annual event, hosted by the Development Research Centre of China’s State Council, has become an important platform of dialogue for the Chinese government, global businesses, academia, and international organizations.
China will continue to welcome enterprises from around the world with open arms, further expand market access, actively address the concerns of businesses, and facilitate the deeper integration of foreign-funded enterprises into the Chinese market, Chinese Premier Li Qiang said in a keynote speech at the opening ceremony of the forum.
Prior to the forum, British pharmaceutical giant AstraZeneca signed a landmark US$2.5-billion agreement on Friday to invest in Beijing over the next five years, the largest single investment in Beijing’s biopharmaceutical sector in recent years.
Under the agreement, AstraZeneca will establish a global strategic R&D centre in Beijing, its sixth worldwide and second in China after one in Shanghai. The new centre, equipped with an advanced artificial intelligence and data science laboratory, will accelerate early-stage drug research and clinical development.
— Xinhua
#GlobalNewLightOfMyanmar